hotspot -WSS

hotspot

author：fashion 2025-09-28 01:16:46 - browse：14143

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Scientists at the Food and Drug Administration have two big questions about Eli Lilly’s experimental Alzheimer’s drug donanemab ahead of a panel of outside experts that it is convening on Monday:

Should the patients who receive the medicine be limited based on PET scans of a protein called tau that Eli Lilly used as a key criteria for trying to determine whether they should receive the drug? That could reduce usage of the medicine by adding a barrier to its use.

And how do the potential risks of using the drug compare to its benefits? The FDA points to one analysis, admittedly with missing data, that could indicate patients who receive the drug have a higher risk of dying.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： How the messy conversation about Dolly changed bioethics

leisure time

WSS

White House Covid adviser calls on docs to combat misinformation

Analysis of telehealth claims data suggest service duplication

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Bill would stop addiction treatment from triggering child abuse inquiry

Phenylephrine and the overlooked value of the placebo effect

entertainment

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

How one medical school became remarkably diverse

Physician executives need more than on

As demand for Covid shots wanes, Moderna seeks its next success

The unintended consequences of overturning Roe v. Wade

How one medical school became remarkably diverse

'A game

DIEP, the 'gold standard' of breast reconstruction, is under threat

Why Charlie Gard's case is so disturbing to Americans

Jerome Adams on the need for new antivirals for Covid

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

focus

FDA panel to weigh safety of artificial wombs for preterm births

Liquid biopsy for lung cancer is launched by Delfi

FDA authorizes Novavax’s updated Covid

House panel takes first step toward fixing drug shortages

Senate panel eyes new effort on drug shortages

The future of health care in the House

hotspot

hotspot

leisure time

explore